Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
Completed · Phase 3 · Has a placebo group
Conditions studied: Acute Heart Failure
In brief
The purpose of the study was to evaluate the efficacy, safety and tolerability of intravenous infusion of serelaxin, when added to standard therapy, in acute heart failure (AHF) patients.
Key facts
- Study ID
- NCT01870778
- Run by
- Novartis Pharmaceuticals
- People needed
- 6600
- Starts
- 2013-10-02
- Expected to finish
- 2017-02-01
- Last updated by the study team
- 2018-03-30
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Novartis Investigative Site — Montgomery, Alabama, United States
- Novartis Investigative Site — Tucson, Arizona, United States
- Novartis Investigative Site — Anaheim, California, United States
- Novartis Investigative Site — Fresno, California, United States
- Novartis Investigative Site — Loma Linda, California, United States
- Novartis Investigative Site — Los Angeles, California, United States
- Novartis Investigative Site — Los Angeles, California, United States
- Novartis Investigative Site — Los Angeles, California, United States
- Novartis Investigative Site — Northridge, California, United States
- Novartis Investigative Site — Palo Alto, California, United States
- Novartis Investigative Site — Sacramento, California, United States
- Novartis Investigative Site — San Diego, California, United States
- Novartis Investigative Site — San Diego, California, United States
- Novartis Investigative Site — San Diego, California, United States
- Novartis Investigative Site — Sylmar, California, United States
- Novartis Investigative Site — Walnut Creek, California, United States
- Novartis Investigative Site — Colorado Springs, Colorado, United States
- Novartis Investigative Site — Denver, Colorado, United States
- Novartis Investigative Site — Hartford, Connecticut, United States
- Novartis Investigative Site — Hartford, Connecticut, United States
- Novartis Investigative Site — Atlantis, Florida, United States
- Novartis Investigative Site — Jacksonville, Florida, United States
- Novartis Investigative Site — Jacksonville, Florida, United States
- Novartis Investigative Site — Jacksonville, Florida, United States
- Novartis Investigative Site — Huntsville, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.